New Enterprise Associates just led a $35 million Series B round for British gene therapy startup NightstaRx, which is developing a viral vector-based therapy for inherited vision loss.

Vori Health picked up $53 million in a series B funding round to build out its physician-led solution for musculoskeletal care. | The startup plans to use the funding to expand its value-based care ...

Vori Health has secured $53m in a Series B funding round, supporting its value-based musculoskeletal care offerings in the US ...